S Oda, T Fukami, T Yokoi, M Nakajima - Drug metabolism and …, 2015 - Elsevier
UDP-glucuronosyltransferase (UGT) and esterases are recognized as the most important non-P450 enzymes because of their high contribution to drug metabolism. UGTs catalyze …
Drug-drug interactions (DDIs) arising from the perturbation of drug metabolising enzyme activities represent both a clinical problem and a potential economic loss for the …
JO Miners, PI Mackenzie, KM Knights - Drug metabolism reviews, 2010 - Taylor & Francis
Major advances in the characterization of uridine diphosphate (UDP)- glucuronosyltransferase (UGT) enzyme substrate and inhibitor selectivities and the …
KM Knights, DM Stresser, JO Miners… - Current protocols in …, 2016 - Wiley Online Library
Abstract Knowledge of the metabolic stability of newly discovered drug candidates eliminated by metabolism is essential for predicting the pharmacokinetic (PK) parameters …
M Chiba, Y Ishii, Y Sugiyama - The AAPS journal, 2009 - Springer
The in vivo metabolic clearance in human has been successfully predicted by using in vitro data of metabolic stability in cryopreserved preparations of human hepatocytes. In the …
N Yang, R Sun, X Liao, J Aa, G Wang - Pharmacological research, 2017 - Elsevier
UDP-glucuronosyltransferases (UGTs) are the primary phase II enzymes catalyzing the conjugation of glucuronic acid to the xenobiotics with polar groups for facilitating their …
[引用][C]Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors
RL Walsky, JN Bauman, K Bourcier, G Giddens… - Drug Metabolism and …, 2012 - ASPET
[引用][C]Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin …
PJ Kilford, R Stringer, B Sohal, JB Houston… - Drug Metabolism and …, 2009 - ASPET